Activated protein C assays: A review

被引:22
作者
Oto, Julia [1 ]
Fernandez-Pardo, Alvaro [1 ]
Miralles, Manuel [1 ,2 ,3 ]
Plana, Emma [1 ,2 ,3 ]
Espana, Francisco [1 ]
Navarro, Silvia [1 ]
Medina, Pilar [1 ]
机构
[1] Hosp La Fe IIS La Fe, Med Res Inst, Haemostasis Thrombosis Atherosclerosis & Vasc Bio, Valencia, Spain
[2] La Fe Univ, Angiol & Vasc Surg Serv, Valencia, Spain
[3] Polytech Hosp, Valencia, Spain
关键词
Activated protein C; Protein C; ELISA; Enzyme capture assay; Venous thrombosis; Protein C inhibitor; RECEPTOR GENE; PLASMA-LEVELS; INTRAVASCULAR COAGULATION; ANTICOAGULANT; INFLAMMATION; RISK; POLYMORPHISMS; INHIBITOR; QUANTIFICATION; DEFICIENCY;
D O I
10.1016/j.cca.2019.11.005
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Activated protein C (APC) acts as an "on demand" anticoagulant, reducing thrombin formation. Reduced plasma levels of APC or protein C (PC) are associated with an increased risk of venous thromboembolism. APC also displays cytoprotective functions and its therapeutic use has been evaluated in severe sepsis and is under evaluation in several diseases with an important inflammatory component. In addition, different studies have revealed a potential role of PC/APC in disorders such as obesity, pneumonia, disseminated intravascular coagulation, Alzheimer, stroke, etc. Accordingly, the therapeutic value of different recombinant APC molecules that lack anticoagulant activity but retain the cytoprotective function is being tested in clinical trials for some of these diseases. Therefore, an available method to measure circulating APC in plasma is of great interests. About 16 different methods for the quantification of APC have been reported. Here, we will review the available assays, highlighting their advantages and disadvantages as well as their different stages of implementation and the most appropriate use for each method, including their potential clinical usefulness.
引用
收藏
页码:227 / 232
页数:6
相关论文
共 57 条
[1]   ACTIVATION OF THE PROTEIN-C PATHWAY IN ACUTE SEPSIS [J].
ALCARAZ, A ;
ESPANA, F ;
SANCHEZCUENCA, J ;
ZUAZU, I ;
ESTELLES, A ;
AZNAR, J ;
VICENTE, V .
THROMBOSIS RESEARCH, 1995, 79 (01) :83-93
[2]   DETECTION OF PROTEIN-C ACTIVATION IN HUMANS [J].
BAUER, KA ;
KASS, BL ;
BEELER, DL ;
ROSENBERG, RD .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (06) :2033-2041
[3]   The evolution of activated protein C plasma levels in septic shock and its association with mortality: A prospective observational study [J].
Becher, Tobias ;
Mueller, Jens ;
Akin, Ibrahim ;
Baumann, Stefan ;
Bosch, Katharina ;
Stach, Ksenija ;
Borggrefe, Martin ;
Poetzsch, Bernd ;
Lossnitzer, Dirk .
JOURNAL OF CRITICAL CARE, 2018, 47 :41-48
[4]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[5]   Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective [J].
Cheng, T ;
Liu, D ;
Griffin, JH ;
Fernández, JA ;
Castellino, F ;
Rosen, ED ;
Fukudome, K ;
Zlokovic, BV .
NATURE MEDICINE, 2003, 9 (03) :338-342
[6]   ANIMAL STUDIES OF PROTEIN-C PHYSIOLOGY [J].
COMP, PC .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1984, 10 (02) :149-153
[7]   Dendrimer modified 8-channel screen-printed electrochemical array system for impedimetric detection of activated protein C [J].
Erdem, Arzum ;
Congur, Gulsah .
SENSORS AND ACTUATORS B-CHEMICAL, 2014, 196 :168-174
[8]   Inflammation and the activated protein C anticoagulant pathway [J].
Esmon, Charles T. .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2006, 32 :49-60
[9]  
Espana F., 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P119, DOI 10.2174/1568016053544336
[10]  
España F, 2001, THROMB HAEMOSTASIS, V86, P1368